Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 23.71% is in line with its 5-year average of 21.81%, near the low end of its 5-year range (18.66%–42.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.92% above its 12-month average of 23.50%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
23.71%
EBITDA MARGIN AVG TTM
23.50%
EBITDA MARGIN AVG 3Y
22.79%
EBITDA MARGIN AVG 5Y
21.81%
EBITDA MARGIN AVG 10Y
21.34%
EBITDA MARGIN AVG 15Y
22.07%
EBITDA MARGIN AVG 20Y
21.57%
CURRENT VS TTM AVG
+0.92%
CURRENT VS 3Y AVG
+4.04%
CURRENT VS 5Y AVG
+8.72%
CURRENT VS 10Y AVG
+11.10%
CURRENT VS 15Y AVG
+7.45%
CURRENT VS 20Y AVG
+9.96%
Encompass Health Corporation
Market Cap
$11.86B
EBITDA Margin
23.71%
TTM Avg
23.50%
3Y Avg
22.79%
5Y Avg
21.81%
Market Cap
$11.38B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$11.35B
EBITDA Margin
28.74%
TTM Avg
23.07%
3Y Avg
27.33%
5Y Avg
30.04%
Market Cap
$12.38B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$11.13B
EBITDA Margin
20.41%
TTM Avg
18.54%
3Y Avg
20.94%
5Y Avg
21.85%
Market Cap
$10.50B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
Market Cap
$10.45B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Encompass Health Corporation (EHC) | $11.86B | 23.71% | 23.50% | 22.79% | 21.81% |
| DaVita Inc. (DVA)vs › | $11.48B | 19.98% | 20.97% | 19.78% | 20.10% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 19.75% | 19.29% | 19.87% | 21.06% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 28.74% | 23.07% | 27.33% | 30.04% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -11.84% | -53.07% | -52.51% | -64.32% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 20.41% | 18.54% | 20.94% | 21.85% |
| Penumbra, Inc. (PEN)vs › | $12.64B | 14.73% | 11.96% | 9.26% | 5.60% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.50B | 18.42% | 17.41% | 19.12% | 20.05% |
| Universal Health Services, Inc. (UHS)vs › | $10.45B | 15.05% | 14.69% | 13.35% | 14.10% |
| Molina Healthcare, Inc. (MOH)vs › | $10.37B | 2.15% | 3.41% | 4.20% | 4.49% |
Gross Margin
95.7%
EBITDA Margin
23.7%
Operating Margin
18.0%
Net Margin
10.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 23.71% |
| 2026-03-31 | 24.51% |
| 2025-12-31 | 23.94% |
| 2025-09-30 | 22.06% |
| 2025-06-30 | 23.26% |
| 2025-03-31 | 23.79% |
| 2024-12-31 | 22.09% |
| 2024-09-30 | 21.28% |
| 2024-06-30 | 22.17% |
| 2024-03-31 | 21.11% |
| 2023-12-31 | 41.30% |
| 2023-09-30 | 41.24% |
| 2023-06-30 | 42.27% |
| 2023-03-31 | 41.74% |
| 2022-12-31 | 21.37% |
| 2022-09-30 | 19.32% |
| 2022-06-30 | 19.76% |
| 2022-03-31 | 19.85% |
| 2021-12-31 | 18.66% |
| 2021-09-30 | 21.99% |
| 2021-06-30 | 21.93% |
| 2021-03-31 | 21.96% |
| 2020-12-31 | 21.02% |
| 2020-09-30 | 19.91% |
| 2020-06-30 | 14.90% |
| 2020-03-31 | 20.46% |
| 2019-12-31 | 18.66% |
| 2019-09-30 | 19.54% |
| 2019-06-30 | 19.67% |
| 2019-03-31 | 21.35% |
| 2018-12-31 | 19.67% |
| 2018-09-30 | 21.01% |
| 2018-06-30 | 21.20% |
| 2018-03-31 | 20.55% |
| 2017-12-31 | 21.33% |
| 2017-09-30 | 21.24% |
| 2017-06-30 | 20.85% |
| 2017-03-31 | 21.71% |
| 2016-12-31 | 21.77% |
| 2016-09-30 | 22.54% |
| 2016-06-30 | 23.12% |
| 2016-03-31 | 22.71% |
| 2015-12-31 | 22.28% |
| 2015-09-30 | 22.09% |
| 2015-06-30 | 22.71% |
| 2015-03-31 | 22.00% |
| 2014-12-31 | 22.51% |
| 2014-09-30 | 23.93% |
| 2014-06-30 | 25.74% |
| 2014-03-31 | 24.45% |
| 2013-12-31 | 25.36% |
| 2013-09-30 | 24.12% |
| 2013-06-30 | 23.80% |
| 2013-03-31 | 25.21% |
| 2012-12-31 | 22.82% |
| 2012-09-30 | 22.96% |
| 2012-06-30 | 23.31% |
| 2012-03-31 | 23.46% |
| 2011-12-31 | 78.36% |
| 2011-09-30 | 22.04% |
| 2011-06-30 | 23.92% |
| 2011-03-31 | 23.58% |
| 2010-12-31 | 21.93% |
| 2010-09-30 | 20.31% |
| 2010-06-30 | 20.50% |
| 2010-03-31 | 21.63% |
| 2009-12-31 | 19.72% |
| 2009-09-30 | 17.96% |
| 2009-06-30 | 11.40% |
| 2009-03-31 | 23.28% |
| 2008-12-31 | 12.66% |
| 2008-09-30 | 12.82% |
| 2008-06-30 | 19.75% |
| 2008-03-31 | 26.52% |
| 2007-12-31 | 18.59% |
| 2007-09-30 | 16.95% |
| 2007-06-30 | 15.06% |
| 2007-03-31 | 10.67% |
| 2006-12-31 | 13.30% |
| 2006-09-30 | 11.61% |
| 2006-06-30 | 15.08% |
| 2006-03-31 | 10.51% |
| 2005-12-31 | 56.65% |
| 2005-09-30 | 19.22% |
| 2005-06-30 | 12.04% |
| 2005-03-31 | -9.12% |
| 2004-12-31 | 1.35% |
| 2003-12-31 | -57.65% |
| 2002-12-31 | -22.01% |
| 2002-09-30 | 35.32% |
| 2002-06-30 | 42.63% |
| 2002-03-31 | 41.69% |
| 2001-12-31 | 42.92% |
| 2001-09-28 | 42.47% |
| 2001-06-30 | 42.72% |
| 2001-03-31 | 40.87% |
